Revenue segments as reported by the company.

Clearing and transaction fees

Market data and information services

Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Compensation and benefits  

Technology

Professional fees and outside services

Amortization of purchased intangibles

Depreciation and amortization

Licensing and other fee agreements

Other expenses

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CME Group

CME Group, Inc. operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals. It offers futures and options on futures trading across asset classes through the CME Globex platform, fixed income trading via BrokerTec and FX trading on the EBS platform. In addition, it also operates CME Clearing, a central counterparty clearing provider. The company was founded in 1898 and is headquartered in Chicago, IL.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CME Group achieves record-breaking 2022 performance amidst market challenges

CME Group's 2022 performance was exceptional, marked by record volumes, revenue growth, and successful transitions. The company's focus on innovation, strategic positioning in energy and cryptocurrency markets, and pricing adjustments have driven positive outcomes. Challenges in margins and market uncertainties require careful navigation.

CME Group posts record Q1 earnings, eyes growth in SOFR

CME Group delivered a strong performance in Q1 2023, achieving record revenue and profitability driven by growth in interest rate and options trading.
The company's strategic focus on risk management, shareholder value creation, and market competitiveness positions it well for future growth and revenue generation.
While facing challenges in a competitive market environment, CME Group has opportunities to capitalize on the demand for SOFR products and options trading.
Optimism surrounding the company's future growth potential, coupled with effective expense management and revenue diversification, underpin its resilience and strategic outlook.

CME Group excels in Q2 with record revenue and strategic focus

CME Group's Q2 earnings call showcased strong financial performance, driven by growth across asset classes and a focus on customer-centric strategies. The company's emphasis on innovation, regulatory compliance, and market leadership positions it well for future growth.

CME Group reports strong Q3 earnings, eyes growth amid challenges

CME Group's Q3 2023 earnings call highlighted robust financial performance, operational efficiency, and strategic positioning. Despite facing regulatory challenges and cost management concerns, the company remains confident in its offerings and growth prospects. Opportunities for expansion through innovation and capitalizing on market trends were key discussion points.

CME Group achieves record 2023 results amidst global uncertainties

CME Group's record-breaking performance in 2023 underscores its market leadership and financial strength, with revenue growth, margin expansion, and strong product demand driving positive results.
While facing challenges from global uncertainties and market dynamics, the company's strategic focus on innovation, risk management, and efficiency positions it well to capitalize on opportunities in evolving markets.
By introducing new products, expanding partnerships, and navigating changing market conditions adeptly, CME Group demonstrates resilience and adaptability, paving the way for continued growth and success in the financial industry.
Overall, CME Group's strategic initiatives, financial performance, and market positioning reflect a company poised for sustained success, leveraging opportunities and strengths to overcome challenges and drive future growth.

CME Group achieves record earnings in Q1 2024, eyes growth

CME Group delivered a strong performance in Q1 2024, setting records in revenue and earnings.
The company faces challenges in managing expenses amid growth initiatives and competitive dynamics.
However, CME's strengths in market leadership, network infrastructure, and regulatory alignment position it well for future opportunities.
By capitalizing on data services and revenue growth avenues, CME can continue its upward trajectory in the market.

CME Group achieves record Q3 performance amidst regulatory challenges

CME Group's Q3 performance was exceptional, marked by record volumes and financial metrics. Despite challenges in regulatory compliance and competition, the company is well-positioned for growth through strategic opportunities in interest rate products and retail expansion.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Highest-ever November ADV Record SOFR options volume and OI CHICAGO , Dec. 2, 2022 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today reported its November 2022 market statistics, showing average daily volume (ADV) increased 1% to 23.5 million contracts during the month, representing the company's highest November volume on record. Market statistics are available in greater detail at https://cmegroupinc.gcs-web.com/monthly-volume.

CME Group Reports November 2022 Monthly Market Statistics

Automatic Data Processing

Aflac

Broadcom

CVS Health

Diamond Hill Investment Group

Enterprise Products Partners

Fortune Brands Home & Security

National Retail Properties

Realty Income Corp

Snap-on

Simon Property Group

Estimated income for 2022 is up to a record $15,545, while the portfolio continues to crush the S&P 500. Buying was light as the market is up big from the October lows. I am skeptical of the market and expect better prices in the future.

My Dividend Growth Portfolio November Update - Healthcare Services Group Gets The Boot

CHICAGO and LONDON , Dec. 1, 2022 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, and CF Benchmarks, the leading provider of cryptocurrency benchmark indices, today announced plans to launch three new DeFi reference rates and real-time indices, which will be calculated and published daily by CF Benchmarks, beginning December 19. These reference rates and indices are not tradable futures products.

CME Group and CF Benchmarks to Launch Three New DeFi Reference Rates and Real-Time Indices on December 19

RPC or rate-per-contract continues to slide. CME has managed the business with excellent expense and margin control.

Chicago Merc: In A Year Tailor-Made For The CME To Outperform, It Fizzles

CME (CME) reported earnings 30 days ago. What's next for the stock?

CME (CME) Up 1.9% Since Last Earnings Report: Can It Continue?

A compelling product portfolio, global presence, focus on over-the-counter clearing services and effective capital deployment poise CME Group (CME) for growth.

Here's Why Holding CME Group (CME) Stock is a Prudent Move

Cboe Global Markets

Intercontinental Exchange

MarketAxess Holdings

Nasdaq

Product innovation, increased market volatility and a strategic economic market model are expected to aid Securities and Exchanges stocks like ICE, CME, CBOE, NDAQ and MKTX. However, compliance with regulations remains a challenge.

5 Securities and Exchanges Stocks to Gain From Increased Trading

CME Group Inc. balances growing earnings power with flexible and high dividend payoffs. CME Group has traditionally been rewarded with high multiples for these great attributes.

CME Group: Money Machine

Twenty-First Century Fox

Pool

QUALCOMM

B. Riley Financial

Sinclair Inc

SSR Mining

Nasdaq stocks have been some of the hardest hit during the market downturn. In fact, over the last 12 months, the Nasdaq Composite Index has dropped more than 35%.

7 Nasdaq Stocks Set to Soar From 52-Week Lows

Highest-ever October ADV Equity Index volume up 59%, with record E-mini S&P 500 options contracts Record SOFR options volume and OI CHICAGO , Nov. 2, 2022 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today reported its October 2022 market statistics, showing average daily volume (ADV) increased 11% to 22.7 million contracts during the month, representing the company's highest October volume on record. Market statistics are available in greater detail at https://cmegroupinc.gcs-web.com/monthly-volume.

CME Group Reports 11% ADV Growth in October 2022

CHICAGO , Oct. 31, 2022 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced the first day of trading of a new suite of overnight index futures based on the Euro Short-Term Rate (€STR). €STR futures provide an efficient way to hedge European money market rates, with contracts including €STR 3-Month futures and €STR 3-Month Single Contract Basis Spread futures, complemented with €STR vs SOFR inter-commodity spreads.

CME Group Announces First Day of Trading of €STR Futures

CME Group (CME) Q3 results reflect higher revenues, driven by increased trading volume.

CME Group (CME) Q3 Earnings Beat on Higher Trading Volume

CME Group, Inc. (NASDAQ:CME ) Q3 2022 Earnings Conference Call October 26, 2022 8:30 AM ET Company Participants John Peschier - MD, IR Terrence Duffy - Chairman & CEO Sean Tully - Senior MD and Global Head, Rates & OTC Products Tim McCourt - Senior MD & Global Head, Equity & FX Products Derek Sammann - Senior MD and Global Head, Commodities, Options & International Markets John Pietrowicz - CFO Julie Winkler - Senior MD & Chief Commercial Officer Sunil Cutinho - Chief Information Officer Conference Call Participants Richard Repetto - Piper Sandler & Co. Daniel Fannon - Jefferies Alexander Kramm - UBS Michael Cyprys - Morgan Stanley Andrew Bond - Rosenblatt Securities Owen Lau - Oppenheimer Alexander Blostein - Goldman Sachs Group Gautam Sawant - Crédit Suisse Kyle Voigt - KBW Christopher Allen - Citigroup Kenneth Worthington - JPMorgan Chase & Co. Simon Clinch - Atlantic Equities Brian Bedell - Deutsche Bank Operator Hello, and welcome to CME Group Third Quarter 2022 Earnings Call. My name is Sarah, and I will be your coordinator for today's event.

CME Group, Inc. (CME) Q3 2022 Earnings Call Transcript

A surge in trading volumes at CME Group underscores how professional traders have remained far more active than their retail counterparts in 2022.

CME's Earnings Show Not All Exchanges Are Seeing a Trading Slowdown

CME (CME) delivered earnings and revenue surprises of 2.59% and 0.14%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

CME Group (CME) Q3 Earnings and Revenues Beat Estimates

CHICAGO , Oct. 26, 2022 /PRNewswire/ -- CME Group Inc. (NASDAQ: CME) today reported financial results for the third quarter of 2022. The company reported revenue of $1.2 billion and operating income of $739 million for the third quarter of 2022.

CME Group Inc. Reports Third-Quarter 2022 Financial Results

The company posted better-than-expected results in the last quarter, with net revenues increasing 5% y-o-y to $1.24 billion.

CME Group Stock To Beat The Street Expectations In Q3?

CME Group is a Dividend Contender with 12 years of dividend growth.  Shares currently offer a 2.35% dividend yield. CME Group owns and operates various futures market exchanges and benefits from volatility and trading activity.

CME Group: Something Special This Way Comes

LONDON and CHICAGO , Oct. 25, 2022 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, and Marex, one of the largest global metals brokers, today announced that Marex will expand its clients' access to CME Group's base metals markets, starting first with CME Group's global Aluminum futures contract. "We continue to make tremendous progress in growing our physically-delivered Aluminum futures and offering market participants an alternative way to manage their Aluminum price risk," said Jin Chang, Managing Director and Global Head of Metals at CME Group.

CME Group and Marex to Expand Client Access to CME Group Aluminum Futures

Agilent Technologies

Intelsat

Friday's Silly Rally

CME Group's (CME) Q3 earnings are likely to have been aided by improved clearing, transaction fees and other revenues, and market data and information services. However, higher expenses might have been an offset.

CME Group (CME) to Report Q3 Earnings: What's in Store?

Heightened market volatility could prove to be a boon for U.S. exchange operators as higher trading volumes during their third quarter help offset a hit from fewer stock listings so far this year.

Choppy markets likely to boost profit for U.S. exchange operators

CHICAGO , Oct. 17, 2022 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced it will expand its Tokyo Stock Price Index (TOPIX) futures offerings with the launch of U.S. dollar-denominated TOPIX futures on November 21, 2022, pending regulatory review. This new contract will be cash-settled, designed to complement the existing Yen-denominated TOPIX futures contract launched in February 2018.

CME Group to Launch U.S. Dollar-denominated TOPIX Futures on November 21

CHICAGO , Oct. 12, 2022 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced it has named Jonathan Marcus as Senior Managing Director and General Counsel. Marcus will serve as the chief legal advisor for CME Group and will oversee the company's compliance, enterprise risk management, legal and market regulation functions.

CME Group Names Jonathan Marcus as General Counsel

Coterra Energy

Extra Space Storage

Diamondback Energy

Prologis

Signature Bank

Visa

Vici Properties

CEOs love to complain about inflation and rising rates. But a handful of S&P 500 firm are better protected from rising prices than others.

News for CME Group Stock (CME)